Background Progress in characterising the humoral immune response to Severe Acute
Respiratory Syndrome 2 (SARS-CoV-2) has been rapid but areas of uncertainty persist. …

Background As of November 2020, severe acute respiratory syndrome coronavirus 2 has
resulted in 55 million infections worldwide and more than 1.3 million deaths from coronavirus …

Background Understanding the T cell response to SARS-CoV-2 is critical to vaccine
development, epidemiological surveillance and disease control strategies. This systematic review …

Coronavirus 19 (COVID-19) has been associated with both transient and persistent systemic
symptoms that do not appear to be a direct consequence of viral infection. The generation …

UBE2L3 is associated with increased susceptibility to numerous autoimmune diseases, but
the underlying mechanism is unexplained. By using data from a genome-wide association …

Dried blood spot (DBS) samples can be used for the detection of severe acute respiratory
syndrome coronavirus 2 spike antibodies. DBS sampling is comparable to matched serum …

Background: Detecting antibody responses during and after SARS-CoV-2 infection is
essential in determining the seroepidemiology of the virus and the potential role of antibody in …

Objective To determine clinical and ethnodemographic correlates of serological responses
against the SARS-CoV-2 spike glycoprotein following mild-to-moderate COVID-19. Design A …

Background Individuals with primary and secondary immunodeficiency (PID/SID) were shown
to be at risk of poor outcomes during the early stages of the SARS-CoV-2 pandemic. SARS…

Background During the COVID-19 outbreak, reports have surfaced of children who present
with features of a multisystem inflammatory syndrome with overlapping features of Kawasaki …